Expert team delivering innovative solutions

Creating solutions for rapid market analysis

In the realm of clinical diagnostics market access, there’s a noticeable scarcity of accessible data. Payor datasets tailored for the diagnostics industry are in short supply and often come with a hefty price tag. Moreover, they tend to be unstructured, making them labor and resource-intensive for end-users. Often the timeframe to do analyses and develop insights, in practical terms, precludes the use of data vendor solutions.

Our approach

At MA360i, we are committed to delivering innovative solutions that provide our clients with essential market access insights for their current and future portfolio. Our approach involves automation using smart-tags, proprietary algorithms, and AI- powered sentiment analysis, and transforming massive, messy datasets into insights.

Our mission at MA360i is to demystify the intricate and frequently overlooked landscape of market access for diagnostics. We offer user-friendly, rapid, and interactive dashboards equipped with advanced filters, enabling you to:

  • Analyze and annotate top tier diagnostics data, extracting crucial market access insights from payor data
  • Access and evaluate payor coverage policies for clinical diagnostics through our proprietary algorithms and AI language models.
  • Derive insights into payor reimbursement rates in a fast, user friendly platform enriched by connections and smart tags for top tier diagnostics.

Experienced Leadership

Our leadership team boasts decades of experience in market access strategy and market intelligence, ensuring that our clients receive expert guidance and support.

Rick Nida

Rick, the CEO and co-founder of MA360i, brings over two decades of experience in the commercial healthcare and life sciences industry. In 2019, he established NGS Reimbursement Solutions, a boutique consulting firm, following a career spanning 14+ years in molecular diagnostic startups and consulting roles at renowned companies such as CareDx, Novartis Dx, Verinata Health, and Illumina.

With a strong foundation in molecular diagnostics and over a decade of experience in next-generation sequencing (NGS)–based diagnostics, Rick’s leadership at Illumina, where he established the Global Market Access team, was pivotal in helping clients overcome market access and reimbursement challenges across oncology, women’s health, and rare undiagnosed genetic disease markets. He is a frequent invited speaker at national conferences, sharing insights on the evolving landscape of molecular diagnostics, commercialization, coverage, evidence development, and reimbursement.

Aruna Rajan

Aruna, the CSO and co-founder of MA360i, brings two decades of strategic leadership to the healthcare and life sciences sector, helping organizations make high-impact decisions and accelerate ROI through focused market assessments. In 2020 she established Arogyam, a boutique strategy firm. As a leader in Illumina’s Market Insights group, she drove market and competitive analyses that shaped strategy for senior leadership, marketing, investor relations, and sales.

Prior to Illumina, Aruna served as a strategy consultant at Scientia Advisors, supporting life science innovators with data-driven growth strategies. Aruna’s expertise lies in translating complex market challenges into actionable solutions, delivering clear recommendations that move businesses forward.

A different player in the market access space

We leverage our distinctive expertise in reimbursement, analytics, market intelligence, commercialization, and market access, tailored specifically for the diagnostics industry, to unravel critical information, data, and insights to power the industry forward. We’re not a data vendor – we are an information and insights provider. We work with you, by your side, as you plan and build on your business strategy and execution.